The largest database of trusted experimental protocols

4 protocols using gsk2334470

1

Molecular Compound Dissolution and Staining

Check if the same lab product or an alternative is used in the 5 most similar protocols
Various small molecules were purchased for this study and dissolved in dimethyl sulfoxide (DMSO) solution: GSK2334470 (Sigma), Gö6893 (Calbiochem), PF4708671 (Torcis), Akt inhibitor X (Calbiochem), Akt inhibitor VI (H-AVTDHPDRLWAWEKF-OH; Calbiochem), LY294002 (Calbiochem), and rapamycin (Calbiochem). Cellular staining reagents were purchased from Molecular Probes (Fisher Scientific), which included 1,1’-dihexadecyl-3,3,3’,3’-tetramethylindocarbocyanine perchlorate (DiIC16(3); Cat# D384), and MitoTrackerOrange CMTMRos (Cat# M7510).
+ Open protocol
+ Expand
2

Preparation of Kinase Inhibitor Solutions

Check if the same lab product or an alternative is used in the 5 most similar protocols
PDK1 inhibitor GSK2334470, MEK inhibitor PD98059 and RSK inhibitor BI-D1870 were purchased from Sigma-Aldrich and dissolved in DMSO to a final concentration of 10 mM. The obtained solutions were aliquoted and stored at −80 °C.
+ Open protocol
+ Expand
3

Inhibiting PI3K-mTOR Pathway in NK Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies recognizing mouse CD3 (mAb 145-2C11), NKp46 (mAb 29A1.4), NK1.1 (PK136), CD117 (2B8), CD127 (A7R37), Ly49A (A1), Ly49C/I (5E6), CD135 (A2F10), SCA-1 (D7), NKG2D (A10), NKG2A/C/E (20D5), CD11b (mAb M1/70), CD27 (LG.7F9), and isotype controls were purchased from eBioscience or BD. CD1d-PBS157 tetramer was provided by the National Institutes of Health tetramer facility. To inhibit the activities of PI3K–mTOR pathway, NK cells were treated with various inhibitors: 1 µM Torin1 (Tocris), 1 µM GSK2334470 (Sigma-Aldrich), 1 µM AKTi1/2 (EMD Millipore), or 10 µM Ly294002 (EMD Millipore).
+ Open protocol
+ Expand
4

HUVEC Molecular Pathway Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary human umbilical vein endothelial cells (HUVECs) were from the institute of life science, Chongqing Medical University (Chongqing, China). Cell culture materials were purchased from Invitrogen (Carlsbad, CA, USA). Growth media were obtained from Gibco (Grand Island, NY, USA). GSK2334470 and PP242 were products of Sigma (St. Louis, MO, USA). Antibodies against p‐eNOS Ser1177, total‐Akt, p‐Akt Ser473, p‐Akt Thr308, PDK1, and SIN1 were purchased from Cell Signaling Technology (Beverly, MA, USA). Antibodies against total‐eNOS, p‐eNOS Thr495, and β‐actin were obtained from Millipore (Temecula, California).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!